ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Neoleukin Therapeutics Inc

Neoleukin Therapeutics Inc (NLTX)

3.49
0.00
( 0.00% )
Updated: 19:00:00

Neoleukin Therapeutics Inc Financial Summary

The current NLTX market cap is 40.7M. The company's latest EPS is USD -3.1139 and P/E is -7.54.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000925k0
Operating Income -5.57M-31.82M-18.78M-20.13M-22.18M
Net Income -4.53M-15.5M-16.92M-18.49M-20.22M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 07.83M000
Operating Income -70.96M-33.73M-60.7M-59.1M-55.58M
Net Income -69.44M-33.28M-60.69M-57.56M-36.32M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 89.59M222.57M195.35M179.82M164.12M
Total Liabilities 14.35M36.55M24.57M24.81M26.71M
Total Equity 75.24M186.02M170.78M155.01M137.41M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 147.02M210.52M163.26M115.95M222.57M
Total Liabilities 5.34M19.3M20.4M21.62M36.55M
Total Equity 141.69M191.22M142.86M94.33M186.02M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -21.35M-51.42M-21.65M-37.54M-53.11M
Investing 8.68M25.64M29.94M6.32M-22.65M
Financing -361k92.48M-6.52M-6.13M-5.99M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -15.39M-24.58M-47.56M-45.61M-51.42M
Investing -688k-2.22M-3.26M-59.13M25.64M
Financing 82.24M77.14M732k161k92.48M
Market Cap 40.7M
Price to Earnings Ratio -7.54
Price to Sales Ratio 0
Price to Cash Ratio 1.85
Price to Book Ratio 1.47
Dividend Yield -

Share Statistics

Shares Outstanding 11.66M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.14 (3.93%)

Company Info

Company Name Neoleukin Therapeutics Inc
Address corporation trust center 1209 orange st
wilmington, delaware 19802
Website https://www.neoleukin.com
Industry pharmaceutical preparations (2834)